Evidence map›Paper›PMID 37515010›Full record

ArticleVaccines2023

The Relationship between Substance Use Stigma and COVID-19 Vaccine Hesitancy.

Natasha Powell, Bruce Taylor, Anna Hotton, Phoebe Lamuda, Elizabeth Flanagan, Maria Pyra, Russell Brewer, O'Dell Johnson, Harold A Pollack, John A Schneider

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Natasha PowellPritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-9454-7503
Bruce TaylorNORC at the University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-8115-1438
Anna HottonDepartments of Medicine and Public Health, University of Chicago, Chicago, IL 60637, USA.
Phoebe LamudaNORC at the University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-0302-4465
Elizabeth FlanaganNORC at the University of Chicago, Chicago, IL 60637, USA.
Maria PyraDepartment of Medical Social Sciences, Northwestern University, Evanston, IL 60201, USA.
Russell BrewerDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
O'Dell JohnsonSouthern Public Health and Criminal Justice Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0000-0002-3049-924X
Harold A PollackCrown Family School of Social Work, Policy, and Practice, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-1629-1175
John A SchneiderDepartments of Medicine and Public Health, University of Chicago, Chicago, IL 60637, USA.
University of Chicago · USChicago Department of Public Health · USNorthwestern University · USUniversity of Arkansas for Medical Sciences · US

Funding

Survey CoreU2CDA050098 · NIDA · UNIVERSITY OF CHICAGO · PI POLLACK, HAROLD ALEXANDER, SCHNEIDER, JOHN · 2019 to 2019
$17.2M
Reducing Opioid Mortality in Illinois (ROMI)UG1DA050066 · NIDA · UNIVERSITY OF CHICAGO · PI PHO, MAI TUYET, POLLACK, HAROLD ALEXANDER · 2019 to 2023
$15.5M
NIDA NIH HHS U2C DA050098NIDA NIH HHS UG1DA050066
6 · The paper itself

Abstract

Two parallel public health epidemics affecting the United States include the COVID-19 pandemic and a rise in substance use disorders (SUDs). Limited research has examined the potential relationship between these two epidemics. Our objective was therefore to perform an exploratory study in order to examine the association between public stigma toward people with a past history of opioid, methamphetamine, cocaine, and alcohol use disorder and COVID-19 vaccine hesitancy. A national sample of U.S. adults (N = 6515) completed a survey which assessed the degree of negative perceptions toward individuals with a past history of substance use disorders (referred to as substance use stigma) and COVID-19 vaccine hesitancy, along with variables such as racial prejudice, source of health news, and other demographics. We evaluated four multivariable logistic regression models to predict COVID-19 vaccine hesitancy, utilizing substance use stigma toward opioids, methamphetamine, cocaine, and alcohol use as independent variables. We found that COVID-19 vaccine hesitancy was positively associated with substance use stigma toward opioid (AOR = 1.34,

Indexed as

cocaineCOVID-19methamphetamineopioidssubstance use stigmavaccine hesitancy

Identifiers

PMID37515010
PMCPMC10383134
OpenAlexW4383223265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.